US Congress opens impeachment proceedings against President Trump

Agencies
September 25, 2019

Washington, Sept 25: US House Speaker Nancy Pelosi announced the initiation of a formal impeachment inquiry against President Donald Trump over the latter's controversial phone call with the Ukrainian president.

"Today, I'm announcing the House of Representatives is moving forward with an official impeachment inquiry," said the Democratic congresswoman from California in a speech on Tuesday, after she concluded a closed-door meeting with the House Democratic Caucus, Xinhua news agency reported.

Citing Trump's admission this week that he talked about Democratic presidential candidate Joe Biden during the July 25 phone call with Ukrainian President Volodymyr Zelensky, Pelosi said "the actions of the Trump presidency revealed the dishonourable fact of the president's betrayal of his oath of office, betrayal of our national security, and betrayal of the integrity of our elections."

Pelosi said she will direct six House committees to proceed with their investigations into Trump "under that umbrella of impeachment inquiry."

"The president must be held accountable. No one is above the law," she said.

Trump responded immediately to Pelosi's announcement, taking to Twitter and calling the inquiry "a presidential harassment."

The president said the Democrats "never even saw the transcript of the call," adding their decision to impeach him is "a total Witch Hunt!"

Earlier on Tuesday, Trump said he authorized the release of the full transcript of the phone call between him and his Ukrainian counterpart.

The president Trump tweeted from New York, where he was attending the United Nations General Assembly session, that he has "authorized the release tomorrow of the complete, fully declassified and unredacted transcript" of the phone call. "You will see it was a very friendly and totally appropriate call," he added.

The presidential conversation between Washington and Kiev is at the centre of a whistleblower complaint filed in mid-August by an unidentified intelligence official, alleging that Trump interacted inappropriately with a foreign leader and made an unspecified "promise."

Senate Minority Leader Chuck Schumer, Democrat from New York, said Tuesday his chamber voted unanimously in support of the content of the whistleblower complaint being provided to Congress.

"The Senate by unanimous consent passed my resolution calling for the whistleblower complaint to be provided to Congress as required by law," Schumer tweeted.

"That means every GOP Senator supports the whistleblower report being immediately provided to the Senate and House Intel Committees," he added. Acting Director of National Intelligence Joseph Maguire has been withholding the material from congressional committees investigating the scandal.

The Hill, in a Monday report, cited a congressional official as saying Maguire and Michael Atkinson -- inspector general of the intelligence community with which the complaint was filed -- are both expected to testify before the Senate Intelligence Committee later this week.

Maguire is scheduled to appear before the House Intelligence Committee on Thursday, the report added.

On the other side of the aisle, Republicans in both chambers denounced Pelosi's announcement. House Minority Leader Kevin McCarthy called on the Democrats to "put the public before politics."

"Speaker Pelosi happens to be the speaker of this House but she does not speak for America when it comes to this issue. She cannot decide unilaterally what happens here," McCarthy told reporters Tuesday. "They have been investigating this President before he even got elected," he added, referring to the Democrats.

Senate Majority Leader Mitch McConnell, for his part, called the impeachment inquiry a "rush to judgment" by "Washington Democrats."

"This rush to judgment comes just a few hours after President Trump offered to release the details of his phone conversation with President Zelensky," the Republican from Kentucky said in a statement. "It comes despite the fact that committee-level proceedings are already underway to address the whistleblower allegation through a fair, bipartisan, and regular process."

In an attempt to contain the fallout of the scandal, McConnell said Monday that lawmakers should handle the issue through bipartisan cooperation.

"I believe it's extremely important that their work be handled in a secure setting with adequate protections in a bipartisan fashion, and based on facts rather than leaks to the press," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 10,2020

Melbourne, Apr 10: Scientists have identified six drug candidates from more than 10,000 compounds that may help treat COVID-19.

The research, published in the journal Nature, tested the efficacy of approved drugs, drug candidates in clinical trials and other compounds.

"Currently there are no targeted therapeutics or effective treatment options for COVID-19," said Professor Luke Guddat from the University of Queensland in Australia.

"In order to rapidly discover lead compounds for clinical use, we initiated a programme of high-throughput drug screening, both in laboratories and also using the latest computer software to predict how different drugs bind to the virus," Guddat said.

The project targeted the main COVID-19 virus enzyme, known as the main protease or Mpro, which plays a pivotal role in mediating viral replication, the researchers said.

This makes it an attractive drug target for this virus, and as people don't naturally have this enzyme, compounds that target it are likely to have low toxicity, they said.

"We add the drugs directly to the enzyme or to cell cultures growing the virus and assess how much of each compound is required to stop the enzyme from working or to kill the virus. If the amount is small, then we have a promising compound for further studies," said Guddat.

After assaying thousands of drugs, researchers found of the six that appear to be effective in inhibiting the enzyme, one is of particular interest.

"We're particularly looking at several leads that have been subjected to clinical trials including for the prevention and treatment of various disorders such as cardiovascular diseases, arthritis, stroke, atherosclerosis and cancer," Guddat said.

Researchers said compounds that are already along the pipeline to drug discovery are preferred, as they can be further tested as antivirals at an accelerated rate compared to new drug leads that would have to go through this process from scratch.

"With continued and up-scaled efforts we are optimistic that new candidates can enter the COVID-19 drug discovery pipeline in the near future," Guddat said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 2,2020

New Delhi, Jul 2: In the midst of India's tense border standoff with China, the defence ministry on Thursday approved procurement of a number of frontline fighter jets, missile systems and other platforms at a cost of Rs 38,900 crore to bolster the combat capability of the armed forces, officials said.

They said 21 MiG-29 fighter jets are being bought from Russia while 12 Su-30 MKI aircraft will be procured from Russia. The ministry has also approved a separate proposal to upgrade existing 59 MiG-29 aircraft.

The decisions were taken at a meeting of the Defence Acquisition Council (DAC) chaired by Defence Minister Rajnath Singh.

The procurement of 21 MiG-29 and upgrading of the existing fleet of MiG-29 are estimated to cost the government Rs 7,418 crore while purchase of 12 new Su-30 MKI from the Hindustan Aeronautics Ltd will be made at a cost of Rs 10,730 crore, the officials said.

The DAC also approved procurement of long-range land-attack cruise missile systems with a range of 1,000 KM and Astra Missiles for Navy and Air Force.

The officials said cost of these design and development proposals is in the range of Rs 20,400 crore.

"While acquisition of Pinaka missile systems will enable raising additional regiments over and above the ones already inducted, addition of long-range land attack missile systems having a firing range of 1000 KM to the existing arsenal will bolster the attack capabilities of the Navy and the Air Force," said a defence ministry official.

"Similarly induction of Astra Missiles having beyond visual range capability will serve as a force multiplier and immensely add to the strike capability of the Indian Navy and the Indian Air Force," he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
February 1,2020

New Delhi, Feb 1: India on Friday banned the export of personal protection equipment such as masks and clothing amid a global coronavirus outbreak.

It did not give a reason for the ban but it reported its first case of the new coronavirus on Thursday, a woman in Kerala who was a student of Wuhan University in China.

The central Chinese city of Wuhan is the epicentre of the outbreak, and the virus has since spread to more than 9,800 people globally and killed 213 people in China.

Several Indian citizens living in Wuhan will arrive in India by plane on Saturday and be taken to a quarantine centre on the outskirts of the capital New Delhi.

India, the world’s second most heavily populated country after China, has taken measures to ensure that all people arriving from China report to health authorities.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.